Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.
about
Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian PopulationVascular stiffness in insulin resistance and obesityInflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE).Hyperglycemia and hyperlipidemia blunts the Insulin-Inpp5f negative feedback loop in the diabetic heartMitochondrial functional impairment in response to environmental toxins in the cardiorenal metabolic syndromeCorrelation of metabolic syndrome severity with cardiovascular health markers in adolescents.Central nervous system regulation of eating: Insights from human brain imagingArterial Stiffness: A Nexus between Cardiac and Renal Disease.Salt Loading Promotes Kidney Injury via Fibrosis in Young Female Ren2 Rats.Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female miceDiet components can suppress inflammation and reduce cancer risk.Association between prehypertension, metabolic and inflammatory markers, decreased adiponectin and enhanced insulinemia in obese subjects.Existence of a Strong Correlation of Biomarkers and miRNA in Females with Metabolic Syndrome and Obesity in a Population of West Virginia.Metabolic milieu associates with impaired skeletal characteristics in obesityRisk of rheumatoid arthritis in patients with type 2 diabetes: a nationwide population-based case-control study.Fructose and uric acid: is there a role in endothelial function?Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular systemOvernutrition, mTOR signaling, and cardiovascular diseases.Immunosuppressive/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction--a novel mechanism for maintaining vascular functionImmune regulators of inflammation in obesity-associated type 2 diabetes and coronary artery disease.Body mass index, physical activity, and serum markers of inflammation, immunity, and insulin resistance.The pathophysiology of hypertension in patients with obesity.Estrogen and mitochondria function in cardiorenal metabolic syndrome.Combination therapy with oleanolic acid and metformin as a synergistic treatment for diabetes.Helminth infections and type 2 diabetes: a cluster-randomized placebo controlled SUGARSPIN trial in Nangapanda, Flores, Indonesia.Acute phase IL-10 plasma concentration associates with the high risk sources of cardiogenic stroke.Effects of long-term dietary nitrate supplementation in mice.The multifaceted mineralocorticoid receptorLunasin attenuates obesity-related inflammation in RAW264.7 cells and 3T3-L1 adipocytes by inhibiting inflammatory cytokine production.Lipidomic evidence that lowering the typical dietary palmitate to oleate ratio in humans decreases the leukocyte production of proinflammatory cytokines and muscle expression of redox-sensitive genes.Interleukin-1β mediates high glucose induced phenotypic transition in human aortic endothelial cells.Analysis of Inflammatory Mediators in Prediabetes and Newly Diagnosed Type 2 Diabetes PatientsThe role of tissue Renin-Angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness.Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome.Lack of mature lymphocytes results in obese but metabolically healthy mice when fed a high-fat diet.Cardiomyocyte changes in the metabolic syndrome and implications for endogeneous protective strategies.The cardiovascular effects of insulin.Dispelling dogma and misconceptions regarding the most pharmacologically targetable source of reactive species in inflammatory disease, xanthine oxidoreductase.Glucose and acute exercise influence factors secreted by circulating angiogenic cells in vitro.
P2860
Q26752511-C979DE16-8C38-4B6E-92C3-1ACB40689C1BQ26774109-1E60CB4B-14EC-45F5-A7CB-8FF612D1D935Q26796220-DE29C5C0-C31A-4ADD-A53A-F711DFCDA95CQ26830867-DB5746D3-A6E2-42AB-B8B7-81DC7AE2D293Q28583594-602A9AAF-F446-40B4-AE39-BEB66D66112CQ28650861-E13DDDC5-E662-43C1-B7A6-727C94E95967Q30252986-5B647A88-A2D7-465B-A33F-E07BBE4E5B70Q31079099-813143E1-9D13-4BD9-9AC0-70E0FB125FBFQ33625728-75E7BB4D-A296-46D1-8AAC-404D639478CDQ33628045-AE2CF2A4-B456-4475-934C-7F7CC727E2CCQ33644666-7632F75E-810A-486E-B6D6-256D78D656A5Q33758929-F88DDAC3-610E-46BF-BF70-C7CE433AB14EQ33803656-1F7B25B2-372B-4871-8B54-42F5BDAED21EQ33820629-B4CC9E37-F3F9-4AA1-BEBC-53A89417930DQ33825396-185AAB71-7CAE-4148-8F1E-E1E63B6D8384Q33838440-94F20DD1-47A6-40B9-92BC-AF903038E9CBQ33854358-95310245-C47B-4DD5-A0E6-BD3DA4BBE35BQ34062829-02D8FB3C-C21A-4566-AB56-FF70FCE3B6FDQ34519316-C9B1087B-ED0D-4676-88AB-3F70753D2366Q34538722-1908BDF4-CBBB-46BB-96F3-DFD3FA05692CQ34611614-CBDBDC8C-A8A5-41D8-8319-D1B50D17130EQ34642100-444D6E8E-93B0-4CC1-B43B-B1A8120E2D83Q35021492-6B1443B2-4AB4-4313-8878-F8814AED1821Q35054122-A4484706-ABDA-45C0-B7C5-2AC4F04CF460Q35151581-7CD3C805-EE70-41E6-9787-84893D7F6A20Q35317212-DE9D9230-8CE5-41F9-8777-E43D22508F7DQ35553390-41EE734D-7B60-41CD-A2DC-C9D1D36F8CA8Q35763584-B676A8C0-AE9A-4ED0-81A2-21C8431101B6Q35906989-0094E4AA-3C25-4446-825C-D81AC3255EA7Q36275415-23A2119E-C6C5-448C-856F-3996AE546472Q36373163-B05828AD-5853-43C4-9E79-F18F0618B5EBQ36654322-C1005E47-3F7F-44D1-A53B-3C6738939A79Q37104776-41E59C9E-B08C-4FF9-9FCD-2537D97D5623Q37261536-4315D6D0-B18C-4485-B693-AF5840BE2284Q37447055-E179957E-6391-4E1D-8C0F-1895BD6972FCQ37659167-9DD6AAB9-6DCC-4DD4-BC52-321FD546E2C8Q38191658-DB3FE614-3C06-4AB1-B2A7-47146ED46C8FQ38217755-FFA157EE-0D49-4D90-8E99-678BF019E09DQ38494677-4E9E4775-9150-4177-A800-1DC524566787Q38549001-C1C4C8B8-392B-45A9-95FC-AACAA3F48D2C
P2860
Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.
@en
Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.
@nl
type
label
Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.
@en
Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.
@nl
prefLabel
Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.
@en
Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.
@nl
P2093
P2860
P921
P1433
P1476
Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance
@en
P2093
Annayya R Aroor
Guanghong Jia
James R Sowers
Susan McKarns
P2860
P304
P356
10.1016/J.METABOL.2013.07.001
P577
2013-08-08T00:00:00Z